C-Path’s Jane Larkindale, Nick King & @JMSauerPhd are among esteemed authors published in @PLOSONE re: #glutamate dehydrogenase and its potential as a safety and diagnostic #biomarker for early detection of liver injury in patients w/muscle conditions. https://t.co/cQW45B474i
Shortening the Timeline for Developing New Treatments--How the #RareDisease Cures Accelerator-Data and Analytics Platform Can Help, available @ https://t.co/11QdMoKlHS + https://t.co/ZR9fKhUJJO. Want to contribute data? [email protected]. #CPath@RareDiseases@US_FDA#RDCADAP